Renal Week 2009 Anemia - Renal and Urology News

If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Renal Week 2009 Anemia Coverage

Weekly Low-Dose Iron May Reduce Overall Iron Use

Jody A. Charnow November 01, 2009

Smaller and more frequent IV iron dosing may result in a significant overall reduction in total iron use, according to a study presented at ASN's Renal Week 2009.

Why Large Doses of IV Iron Decrease HD Patient Survival Is Unclear

Jody A. Charnow November 01, 2009

Very large doses of IV iron are associated with decreased long-term survival in patients on hemodialysis, but a new analysis presented at ASN's Renal Week 2009 in San Diego probing this association could not establish a convincing reason for the increased mortality.

Anemia Hikes Long-Term Mortality in Non-Diabetic CKD Patients

Jody A. Charnow November 01, 2009

Anemia in non-diabetic CKD patients increases their risk of long-term mortality, and this predominantly explained by the association between anemia and degree of renal function, according to a study presented at ASN's Renal Week 2009.

Replacing HD Water Treatment Components Raises Hemoglobin Levels

Jody A. Charnow November 01, 2009

Preemptive replacement of hemodialysis (HD) water treatment components could result in significantly increased hemoglobin levels at lower doses of erythropoiesis-stimulating agents in HD patients, British researchers reported in a study presented at Renal Week 2009.

Wasting, Inflammation Hike Death Risk in Dialysis Patients with EPO Resistance

Jody A. Charnow October 31, 2009

Dialysis patients who have erythropoietin resistance also suffer from wasting, inflammation, or both, which increases their risk of death, according to researchers in The Netherlands who presented their study at Renal Week 2009.

Hemoglobin Levels Linked to Vitamin D in Diabetic CKD Patients

Jody A. Charnow October 31, 2009

Elevated levels of vitamin D are associated with higher hemoglobin levels in CKD patients with diabetes, according to researchers at the University of Missouri School of Medicine in Columbia in a study presented at ASN's Renal Week 2009.

Data May Help Explain Beneficial Effect of Pentoxifylline in Dialysis Patients with Anemia

Jody A. Charnow October 31, 2009

Pentoxifylline has been reported to improve resistance to erythropoiesis-stimulating agents. New preliminary findings suggest that part of this beneficial effect may be related to better mobilization and utilization of iron in dialysis patients with anemia, according to a study presented at ASN's Renal Week 2009.

Ferric Carboxymaltose Safely Improves Hemoglobin in Dialysis Patients

Jody A. Charnow October 31, 2009

Ferric carboxymaltose given as an IV bolus push injection is well tolerated and effective in correcting hemoglobin levels in hemodialysis patients with iron-deficiency anemia, Romanian researchers reported in a study presented at American Society of Nephrology's Renal Week.

Higher Hemoglobin May Cut Risk of Death, Dialysis Initiation

Jody A. Charnow October 30, 2009

Higher hemoglobin levels reduce the risk of death and dialysis initiation among patients with CKD, according to data presented at ASN's Renal Week 2009.

Heart Failure, Diabetes Attentuate Risk of High Hemoglobin

Jody A. Charnow October 30, 2009

New data suggest that the presence of comorbidities such as heart failure or diabetes renders increased risk of death and cardiovascular morbidity associated with high hemoglobin targets clinically undetectable, according to analysis presented at ASN's Renal Week 2009.

Elevated Hepcidin Linked to Low Erythropoietin Levels

Jody A. Charnow October 30, 2009

High levels of circulating hepcidin are associated with low erythropoietin (EPO) levels in patients with CKD, data show. Elevated hepcidin may be due in part to EPO deficiency.

Ferumoxytol a Safe, Effective Option for CKD Anemia

Jody A. Charnow October 29, 2009

Ferumoxytol, an injection formulation of iron, is a promising treatment for iron deficiency-related anemia, according to Ajay K. Singh, MD.

Lowest Cumulative Erythropoietin Doses Linked to Worse Survival

Jody A. Charnow October 29, 2009

The lowest cumulative erythropoietin (EPO) doses over three years are associated with worse survival among maintenance hemodialysis (MHD) patients, data suggest.

Data Suggest a Mechanism for ESA Resistance

Jody A. Charnow October 29, 2009

Researchers have found evidence that could help explain why some anemic CKD patients are resistant to treatment with an erythropoiesis stimulating agents (ESA).